Bacterial infection alters the kinetics and function of iNKT cell responses.
CD1d-restricted Valpha14 invariant NKT cells (iNKT) are innate-like, immunoregulatory lymphocytes that play critical roles in autoimmunity, tumor surveillance, and infectious disease. Although iNKT cells are activated during microbial infection, the impacts of infection on the function of iNKT cells have not been fully characterized. Using a Listeria monocytogenes (LM) infection model, we found that iNKT cells failed to expand after infection, resulting in prolonged loss in the spleen, in contrast to the typical expansion and contraction of conventional T cells. iNKT cells from LM-infected mice responded more rapidly to secondary LM infection; however, they became functionally hyporesponsive to antigenic challenge for at least 1 month. This infection-induced hyporesponsiveness was also induced by Mycobacteria infection and was more profound in LM-infected, thymectomized mice, suggesting that infection-primed iNKT cells might have altered functionality. Interestingly, activation with alpha-galactosylceramide-loaded dendritic cells was able to overcome infection-induced hyporesponsiveness of iNKT cells, suggesting a role for extrinsic factors in this functional deficit. Taken together, these findings suggest that infection affects iNKT cell responses quantitatively and qualitatively. As humans are under constant microbial insult, predictions of iNKT cell function based on naïve animal models may not accurately reflect iNKT cell behavior in a clinical setting.
Choi
Hak-Jong
HJ
Department of Pathology, University of Chicago, Chicago, IL, USA.
Xu
Honglin
H
Geng
Yanbiao
Y
Colmone
Angela
A
Cho
Hoonsik
H
Wang
Chyung-Ru
CR
D000818:Animals; D017951:Antigen Presentation; D003713:Dendritic Cells / Q000276:immunology; D004195:Disease Models, Animal; D005434:Flow Cytometry; D016898:Interferon-alpha / Q000502:physiology; D008089:Listeria monocytogenes / Q000472:pathogenicity*; D008088:Listeriosis / Q000276:immunology* / Q000473:pathology; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009163:Mycobacterium bovis / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity; D009169:Mycobacterium tuberculosis / Q000276:immunology; D055611:Natural Killer T-Cells / Q000502:physiology*; D010641:Phenotype; D013154:Spleen / Q000276:immunology / Q000382:microbiology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D016898:Interferon-alpha
J Immunol. 2003 Aug 15;171(4):1775-9
12902477
Annu Rev Immunol. 2004;22:817-90
15032598
J Clin Invest. 2008 Jun;118(6):2301-15
18451996
Nat Immunol. 2006 Sep;7(9):978-86
16921381
Trends Immunol. 2007 Nov;28(11):491-6
17964217
Blood. 2004 Jan 15;103(2):383-9
14512316
Infect Immun. 2006 Oct;74(10):5903-13
16988270
J Immunol. 1997 Jul 1;159(1):7-10
9200431
Eur J Immunol. 2005 Mar;35(3):879-89
15724241
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10913-8
12960397
Curr Opin Microbiol. 2004 Feb;7(1):45-50
15036139
Nat Med. 2002 Jun;8(6):588-93
12042809
Eur J Immunol. 2005 Jul;35(7):2100-9
15940666
J Exp Med. 2000 Sep 4;192(5):741-54
10974039
J Immunol. 2006 Dec 1;177(11):7841-8
17114455
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13861-6
12359878
N Engl J Med. 2006 Mar 16;354(11):1117-29
16540612
Clin Immunol. 2008 Apr;127(1):1-6
18304877
J Exp Med. 2005 May 2;201(9):1503-17
15867097
J Immunol. 2002 Dec 1;169(11):6522-9
12444163
Clin Cancer Res. 2005 Mar 1;11(5):1910-7
15756017
J Exp Med. 2005 Nov 7;202(9):1279-88
16275765
Nat Immunol. 2000 Dec;1(6):459-60
11101862
Infect Immun. 2002 Nov;70(11):6302-9
12379709
J Immunol. 2005 Jul 15;175(2):1137-44
16002715
Clin Cancer Res. 2002 Dec;8(12):3702-9
12473579
J Infect Dis. 2007 May 1;195(9):1361-4
17397008
J Immunol. 2003 Oct 15;171(8):4352-8
14530360
J Exp Med. 2003 Apr 7;197(7):907-18
12682110
J Immunol. 2001 Oct 1;167(7):4046-50
11564825
Infect Immun. 2005 Jan;73(1):181-92
15618153
J Infect Dis. 1986 May;153(5):960-9
3084667
Nature. 2005 Mar 24;434(7032):525-9
15791258
J Immunol. 2003 Aug 15;171(4):1961-8
12902499
J Exp Med. 1995 Oct 1;182(4):993-1004
7561702
J Immunol. 2007 Oct 15;179(8):5126-36
17911598
Infect Immun. 2007 May;75(5):2171-80
17353286
Nature. 2005 Mar 24;434(7032):520-5
15791257
Nat Rev Immunol. 2004 Mar;4(3):231-7
15039760
J Immunol. 2001 Mar 1;166(5):3402-9
11207297
J Immunol. 2003 Oct 15;171(8):4020-7
14530322
J Virol. 2001 Jul;75(13):5965-76
11390598
Annu Rev Immunol. 1997;15:535-62
9143699
Nat Med. 2003 May;9(5):582-8
12669034
Nat Rev Microbiol. 2007 Jun;5(6):405-17
17487145
J Exp Med. 2002 Jul 1;196(1):119-27
12093876
J Exp Med. 1999 Apr 19;189(8):1315-28
10209048
J Clin Invest. 2005 Sep;115(9):2572-83
16138194